BioMedWire Stocks Archives - BioMedWire (BMW)

FridaySep 12, 2025 10:00 am

Study Finds That Common Sweetener Could Compromise Cancer Treatment Effectiveness

Researchers at University of Pittsburg have found that patients who consume sucralose regularly have a lower likelihood of benefiting from immunotherapy and having longer survival times. Sucralose is an artificial sweetener that is commonly used in a variety of diet products, such as Splenda. This research is the first to connect the dietary choices that people make to groundbreaking cancer treatments. For their study, the team obtained the dietary data of 91 patients diagnosed with advanced melanoma. They also obtained similar data from 41 patients having lung cancer. The patients whose daily intake of sucralose exceeded 0.07mg for each pound…

ThursdaySep 11, 2025 10:00 am

Kennedy’s MAHA Plan to Make Kids Healthier Receives Mixed Reactions

On Tuesday, the U.S. federal administration published a report aimed at improving the health of children in the country. The report calls for wide-ranging policy changes and executive actions to tackle the chronic disease burden rising in the country. HHS Secretary Kennedy Jr. announced this report. However, reactions to the contents of the report have been mixed. Speaking during the release, Kennedy hailed the 128 recommendations contained in the report as “unprecedented and historic” in addressing the “existential threat” posed by chronic diseases in American kids. Many researchers and experts say the report is rich in rhetoric but thin on…

TuesdaySep 09, 2025 10:00 am

Senior NIH Officials Allege Retaliation as Motive for Their Ouster

Two former officials at the NIH have filed whistleblower complaints in which they allege that their removal from office was a result of their resistance to giving politics priority over science and their efforts to defend vaccines and research grants. They filed their complaints last week. Back in April, Kathleen Neuzil and Jeanne Marazzo were put on administrative leave from their NIH top positions. In their complaints filed last week at the United States Office of Special Counsel, they claim that the work environment at the NIH after Robert F. Kennedy Jr. took over as HHS Secretary became hostile to…

FridaySep 05, 2025 10:00 am

NCI Halts Funding for Consortium Conducting Trials on Childhood Brain Cancers

The NCI, or National Cancer Institute, a federal body, has revealed that it will no longer fund a program that has been running for 26 years focused on advancing clinical studies on children with brain cancers. The group, Pediatric Brain Tumor Consortium, was founded in 1999 to bring together 15 academic institutions and pediatric hospitals within the United States and Canada to conduct early-stage clinical trials (Phase 1 and Phase 2). This consortium has a record of conducting trials aimed at exploring new therapies, strategies for delivering radiation treatment, and finding new technologies to deliver treatments specifically focused on pediatric…

ThursdaySep 04, 2025 10:00 am

Research Uncovers Possible Way to Repair Myelin in MS Patients

According to new research published in the journal Cell, targeting the SOX6 protein could open a new way to repair myelin in individuals afflicted by multiple sclerosis. According to the researchers, this SOX6 protein regulates the maturation of cells referred to as oligodendrocytes which manufacture myelin. The team found that when SOX6 is overactive, as is the case in MS patients, oligodendrocytes remain immature and can’t therefore produce myelin. By targeting SOX6, the researchers believe that myelin production can resume and consequently some form of restoration in function could be achieved in patients. In healthy people, SOX6 is less active,…

FridayAug 29, 2025 10:00 am

Health Care Titans are Filing for Bankruptcy in America

All sectors have their share of bankruptcies every year, but the health care sector is experiencing these filings in a concerning way; major players are going under as the weight of financial headwinds takes a huge toll. The health care system has variously been described as being in the throes of a crisis, and companies within the system are no exception. The yearly average for bankruptcy filings in America has been approximately 42, but a recent report authored by Gibbins Advisors says that in 2023 there were 79 such filings while 2024 had 57 bankruptcy filings. Bankruptcy filings seem to…

ThursdayAug 28, 2025 10:00 am

Study Explains Why Blood Clotting is Common in IBD Patients

About 3 million people in the U.S. live with irritable bowel disease (IBD), and its prevalence is rising. Unfortunately, there isn’t a cure for the condition at the moment. Many individuals with IBD develop clots in their blood and these can result in strokes and heart attacks. Now a new study has discovered possible reasons why these clots are common and suggests a possible way to address this problem while also reducing inflammation. The team, whose study author is Rebecca Mellema, explains that platelets in IBD patients are hyper-primed to clot at the smallest provocation. This is because the inbuilt…

TuesdayAug 26, 2025 10:00 am

Blocking Glioblastoma-Triggered Brain Damage Could Slow the Aggressive Tumor’s Growth

According to new research conducted by a team at University College London, blocking the brain damage caused by glioblastoma could keep the patient’s brain working better for a much longer time and also slow the pace at which the tumor grows. The study used a mouse model and found that when glioblastoma tumors are in their early stage, they damage axons (parts of the nerves in the brain). When this damage occurs, according to the findings of the researchers, the brain responds to this injury to its nerve cells by first breaking down and then removing those damaged axons from…

FridayAug 22, 2025 10:00 am

Pioneering Therapy Could Slow the Effects of Aging

A new groundbreaking therapy could slow down or even reverse aging by recharging body cells with new “batteries” that provide new energy for bodily function. The new therapy utilizes mitochondria from the placenta of infants, which are then transplanted into older people or those suffering from diseases that are currently regarded as incurable. Minovia Therapeutics, a company based in Israel, is the first firm globally to test mitochondria transplantation in human beings as a way to help people remain younger for a longer time and also treat conditions that are regarded as incurable. Mitochondria are tiny organelles within cells, and…

ThursdayAug 21, 2025 10:00 am

Scientists Turn Bacteria into Trojan Horses to Deliver Anti-Cancer Viruses into Tumors

Scientists at Columbia University have engineered a cancer treatment that leverages bacteria to smuggle cancer-killing viruses into tumors in a method that sidesteps the defenses of the immune system. This groundbreaking approach utilizes two vital weapons against the cancer; the bacteria are drawn to cancer cells, and the viruses inside the bacteria deliver the killer blow to the tumor cells after being delivered there by the bacteria. The study team was successful in creating built-in safeguards intended to prevent the viruses from infiltrating and infecting tissues outside the tumor environment. Their research promises to introduce a new paradigm in the…